Latest Breaking News On - Eiger biopharmaceuticals company profile - Page 1 : comparemela.com

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesEiger biopharmaceuticals company profileEiger biopharmaceuticals incEiger biopharmaceuticalsFree reportGet free reportEiger biopharmaceuticals daily

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance The stock’s 50-day moving average is $5.04 and its 200 day moving average is $7.14. The firm has a market cap […]

United statesEiger biopharmaceuticals company profileBarclays plcEiger biopharmaceuticals incCapital managementMillennium managementAmeriprise financial incEiger biopharmaceuticalsFree reportGet free reportEiger biopharmaceuticals daily

Eiger BioPharmaceuticals (NASDAQ:EIGR) Earns Sell Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance The firm has a 50 day moving average of $5.04 and a 200-day moving average of $7.14. Eiger BioPharmaceuticals has a […]

United statesMorgan stanleyEiger biopharmaceuticals incAmeriprise financial incVanguard group incBarclays plcEiger biopharmaceuticals company profileEiger biopharmaceuticalsFree reportStreet corpGet free reportEiger biopharmaceuticals daily

Eiger BioPharmaceuticals (EIGR) Set to Announce Quarterly Earnings on Thursday

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) will be announcing its earnings results on Thursday, March 14th. Eiger BioPharmaceuticals Price Performance EIGR stock opened at $5.90 on Wednesday. The firm has a market capitalization of $8.73 million, a PE ratio of -0.10 and a beta of 1.85. Eiger BioPharmaceuticals has a 1 year low of […]

Hong kongUnited statesCapital partnersIntercept hong kong ltdEiger biopharmaceuticals company profileEiger biopharmaceuticals incEiger biopharmaceuticalsGet free reportEiger biopharmaceuticals daily

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Down 0.3 % EIGR stock opened at $5.80 on Monday. The firm has a 50 day moving average of $6.89 […]

United statesEiger biopharmaceuticals company profileMorgan stanleyVanguard group incAmeriprise financial incEiger biopharmaceuticals incBarclays plcEiger biopharmaceuticalsFree reportBiopharmaceuticals stock downStreet corpGet free reportEiger biopharmaceuticals dailyNasdaq eigrInitiated coverageStocknews com